Prochlorperazine Edisylate

CAS 1257-78-9 4 current records 3 historicalSmall Molecule

Who holds supplier records for Prochlorperazine Edisylate? 4 organisations hold a current record for Prochlorperazine Edisylate: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (3) and Italy (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 13 Nov 2026. How we read these records

Cite as: PharmaTek, “Prochlorperazine Edisylate: DMF and CEP holder records”, record as of 13 Nov 2026, pharmatek.co.uk/directory/api/prochlorperazine-edisylate

Reading the evidence

  • 4 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    3 of the 4 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (4)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Prochlorperazine Edisylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Prochlorperazine Edisylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (3)

Organisations whose Type II DMFs for Prochlorperazine Edisylate are no longer active. These show a past filing, not current supply.

Show all 3 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Prochlorperazine Edisylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201154).

Chemical identity

IUPAC name
2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine;ethane-1,2-disulfonic acid
Canonical SMILES
CN1CCN(CC1)CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl.C(CS(=O)(=O)O)S(=O)(=O)O
InChIKey
SWOUGRBFXFILIB-UHFFFAOYSA-N
Synonyms
Compazine, NSC-757299, Prochlorperazine edisilate, Prochlorperazine edisylate, Prochlorperazine edisylate salt, prochlorperazine ethanedisulfonate, Prochlorperazine edisylate (USP), Prochlorperazine edisylate [USP], NSC665801, RefChem:55922, Prochlorperazine Edisylate, USP, Prochlorperazine ethane disulfonate

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Phenothiazine
Chemical structure
Phenothiazines

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Prochlorperazine Edisylate?

4 organisations hold an active US FDA Type II Drug Master File or a CEP for Prochlorperazine Edisylate: BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India), Emcure Pharmaceuticals Limited (India), RAKS PHARMA PVT LTD (India) and TRIFARMA SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Prochlorperazine Edisylate Drug Master Files are active?

BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 32178), Emcure Pharmaceuticals Limited (DMF 31176), RAKS PHARMA PVT LTD (DMF 33693) and TRIFARMA SPA (DMF 16055). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Prochlorperazine Edisylate records mean?

3 organisations have only inactive Type II DMFs for Prochlorperazine Edisylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Prochlorperazine Edisylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Prochlorperazine Edisylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.